Malignant Hyperthermia
πͺ Definition: Malignant Hyperthermia (MH) is a rare, life-threatening pharmacogenetic disorder of skeletal muscle, triggered by certain anaesthetic agents (volatile agents, suxamethonium), leading to uncontrolled intracellular calcium release and a hypermetabolic crisis.
πͺ¨ Triggers:
Volatile anaesthetic agents (e.g. sevoflurane, desflurane)
Succinylcholine (suxamethonium)
π€ Pathophysiology:
Mutation in RYR1 (ryanodine receptor) gene β excess calcium release from sarcoplasmic reticulum
Sustained muscle contraction, ATP depletion, heat and lactic acid production
Clinical Features:
π’ EtCOβ β
Early sign; rises despite hyperventilation
π‘οΈ Hyperthermia
| Often a late sign
β€οΈ Tachycardia
Often first cardiovascular sign
π§± Muscle rigidity
Generalised or masseter spasm
π Acidosis
Metabolic Β± respiratory
β¨ Hyperkalaemia
May lead to arrhythmias
π³ Myoglobinuria
Risk of AKI
π CK β
Rhabdomyolysis marker
π Key Investigations:
Arterial blood gas (ABG): Acidosis, hyperkalaemia, lactate
CK, serum myoglobin, renal function
Core temperature
Urinalysis for pigment
π Management: Use "S.A.F.E.R."
π΄ S
Stop the trigger: Cease volatile agent/suxamethonium, remove vaporiser
πͺ A
Airway + 100% Oβ: Hyperventilate to clear COβ and reduce acidosis
π§ͺ F
First-line therapy: Give Dantrolene 2.5 mg/kg IV, repeat q5-10 min (max 10 mg/kg)
π’ E
Escalate: Call for help, delegate dantrolene prep (2 staff), notify retrieval/ICU early
π R
Rescue planning: Insert IDC, cool patient, monitor for complications, prep transfer
Supportive Measures:
Active cooling: IV cold fluids, ice packs, fan
Treat hyperkalaemia: Calcium chloride/gluconate, insulin + dextrose
Insert arterial line, urinary catheter
Serial monitoring: ABG, CK, renal function
π₯ Post-Event Management:
Do NOT extubate early
ICU admission mandatory
Refer for confirmatory testing (e.g. caffeine halothane contracture test (CHCT) or genetic RYR1 testing)
Family screening + documentation
π Scenarioville Context Considerations:
Check MH kit weekly (stock dantrolene and protocol)
At least 2 staff required for reconstituting traditional dantrolene (20 mg/vial)
Maintain up-to-date MH policy and liaise with centralised retrieval service early
π‘ Pro Tip for Viva:
"I would apply the SAFE-R mnemonic to structure my response, emphasise early dantrolene, team delegation, supportive care, and prompt ICU retrieval from Scenarioville."
Last updated